Loading...

ITL Health Group

ASX:ITD
Snowflake Description

Mediocre balance sheet with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ITD
ASX
A$10M
Market Cap
  1. Home
  2. AU
  3. Healthcare
Company description

ITL Health Group Limited develops, manufactures, distributes, and sells medical devices in Australia, the United States, the United Kingdom, Puerto Rico, France, and internationally. The last earnings update was 171 days ago. More info.


Add to Portfolio Compare Print
  • ITL Health Group has significant price volatility in the past 3 months.
ITD Share Price and Events
7 Day Returns
0%
ASX:ITD
-0.5%
AU Medical Equipment
0.4%
AU Market
1 Year Returns
-62.8%
ASX:ITD
5.1%
AU Medical Equipment
1.8%
AU Market
ITD Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
ITL Health Group (ITD) 0% 0% -3.3% -62.8% -27.5% -50%
AU Medical Equipment -0.5% 5% 18.5% 5.1% 48.2% 99.9%
AU Market 0.4% 4.3% 5.9% 1.8% 25.9% 3.7%
1 Year Return vs Industry and Market
  • ITD underperformed the Medical Equipment industry which returned 5.1% over the past year.
  • ITD underperformed the Market in Australia which returned 1.8% over the past year.
Price Volatility
ITD
Industry
5yr Volatility vs Market

ITD Value

 Is ITL Health Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for ITL Health Group. This is due to cash flow or dividend data being unavailable. The share price is A$0.145.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for ITL Health Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are ITL Health Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:ITD PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in AUD A$-0.07
ASX:ITD Share Price ** ASX (2019-02-08) in AUD A$0.15
Australia Medical Equipment Industry PE Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 20.08x
Australia Market PE Ratio Median Figure of 559 Publicly-Listed Companies 15.71x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of ITL Health Group.

ASX:ITD PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:ITD Share Price ÷ EPS (both in AUD)

= 0.15 ÷ -0.07

-2.14x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • ITL Health Group is loss making, we can't compare its value to the AU Medical Equipment industry average.
  • ITL Health Group is loss making, we can't compare the value of its earnings to the Australia market.
Price based on expected Growth
Does ITL Health Group's expected growth come at a high price?
Raw Data
ASX:ITD PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.14x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
49.1%per year
Global Medical Equipment Industry PEG Ratio Median Figure of 107 Publicly-Listed Medical Equipment Companies 2.51x
Australia Market PEG Ratio Median Figure of 361 Publicly-Listed Companies 1.42x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for ITL Health Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on ITL Health Group's assets?
Raw Data
ASX:ITD PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in AUD A$0.18
ASX:ITD Share Price * ASX (2019-02-08) in AUD A$0.15
Australia Medical Equipment Industry PB Ratio Median Figure of 29 Publicly-Listed Medical Equipment Companies 2.11x
Australia Market PB Ratio Median Figure of 1,664 Publicly-Listed Companies 1.65x
ASX:ITD PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:ITD Share Price ÷ Book Value per Share (both in AUD)

= 0.15 ÷ 0.18

0.83x

* Primary Listing of ITL Health Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • ITL Health Group is good value based on assets compared to the AU Medical Equipment industry average.
X
Value checks
We assess ITL Health Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. ITL Health Group has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

ITD Future Performance

 How is ITL Health Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover ITL Health Group, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
49.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is ITL Health Group expected to grow at an attractive rate?
  • ITL Health Group's earnings growth is expected to exceed the low risk savings rate of 2.3%.
Growth vs Market Checks
  • ITL Health Group's earnings growth is expected to exceed the Australia market average.
  • Unable to compare ITL Health Group's revenue growth to the Australia market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
ASX:ITD Future Growth Rates Data Sources
Data Point Source Value (per year)
ASX:ITD Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 49.1%
Australia Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 12.4%
Australia Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 9.3%
Australia Market Earnings Growth Rate Market Cap Weighted Average 5.9%
Australia Market Revenue Growth Rate Market Cap Weighted Average 2.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:ITD Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (7 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:ITD Future Estimates Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
ASX:ITD Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-06-30 21 -1 -6
2018-03-31 21 0 -3
2017-12-31 34 1 1
2017-09-30 34 3 2
2017-06-30 23 5 3
2017-03-31 25 3 2
2016-12-31 27 2 1
2016-09-30 29 1 1
2016-06-30 31 0 0
2016-03-31 30 1 1
2015-12-31 30 2 2
2015-09-30 29 1 2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • ITL Health Group's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if ITL Health Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:ITD Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (7 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from ITL Health Group Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:ITD Future Estimates Data
Date (Data in AUD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
ASX:ITD Past Financials Data
Date (Data in AUD Millions) EPS *
2018-06-30 -0.07
2018-03-31 -0.03
2017-12-31 0.01
2017-09-30 0.02
2017-06-30 0.03
2017-03-31 0.02
2016-12-31 0.01
2016-09-30 0.01
2016-06-30 0.00
2016-03-31 0.01
2015-12-31 0.02
2015-09-30 0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if ITL Health Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess ITL Health Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
ITL Health Group has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

ITD Past Performance

  How has ITL Health Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare ITL Health Group's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • ITL Health Group does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare ITL Health Group's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare ITL Health Group's 1-year growth to the AU Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
ITL Health Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from ITL Health Group Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:ITD Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 21.36 -6.14 10.61 0.61
2018-03-31 21.38 -2.59 10.10 0.45
2017-12-31 33.62 1.12 11.08 0.28
2017-09-30 34.20 2.27 10.82 0.26
2017-06-30 22.55 3.28 9.07 0.24
2017-03-31 24.63 2.34 9.24 0.30
2016-12-31 26.70 1.40 9.41 0.35
2016-09-30 28.89 0.87 9.35 0.35
2016-06-30 31.08 0.34 9.30 0.35
2016-03-31 30.48 0.94 9.14 0.27
2015-12-31 29.88 1.54 8.98 0.18
2015-09-30 29.11 1.83 8.95 0.12
2015-06-30 28.33 2.12 8.91 0.07
2015-03-31 27.70 2.28 8.58 0.03
2014-12-31 27.06 2.43 8.24
2014-09-30 26.46 2.23 8.04
2014-06-30 25.86 2.02 7.84
2014-03-31 25.27 2.11 7.59
2013-12-31 24.67 2.21 7.34
2013-09-30 24.78 2.33 7.27
2013-06-30 24.89 2.46 7.21
2013-03-31 25.72 2.57 7.66
2012-12-31 26.56 2.69 8.12
2012-09-30 27.42 2.72 8.08
2012-06-30 28.28 2.75 8.04

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if ITL Health Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if ITL Health Group has efficiently used its assets last year compared to the AU Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if ITL Health Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess ITL Health Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
ITL Health Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

ITD Health

 How is ITL Health Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up ITL Health Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • ITL Health Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • ITL Health Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of ITL Health Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 3.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from ITL Health Group Company Filings, last reported 7 months ago.

ASX:ITD Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 15.05 4.26 3.83
2018-03-31 15.05 4.26 3.83
2017-12-31 20.46 4.29 4.72
2017-09-30 20.46 4.29 4.72
2017-06-30 17.61 5.28 2.69
2017-03-31 17.61 5.28 2.69
2016-12-31 16.15 6.38 1.37
2016-09-30 16.15 6.38 1.37
2016-06-30 14.27 6.14 0.61
2016-03-31 14.27 6.14 0.61
2015-12-31 14.66 6.10 1.46
2015-09-30 14.66 6.10 1.46
2015-06-30 11.88 5.65 1.10
2015-03-31 11.88 5.65 1.10
2014-12-31 12.01 5.33 1.62
2014-09-30 12.01 5.33 1.62
2014-06-30 10.00 3.70 0.12
2014-03-31 10.00 3.70 0.12
2013-12-31 10.15 4.56 0.65
2013-09-30 10.15 4.56 0.65
2013-06-30 10.80 1.70 0.41
2013-03-31 10.80 1.70 0.41
2012-12-31 12.08 1.29 0.58
2012-09-30 12.08 1.29 0.58
2012-06-30 12.81 0.04 1.01
  • ITL Health Group's level of debt (28.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (16% vs 28.3% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • ITL Health Group is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess ITL Health Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. ITL Health Group has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

ITD Dividends

 What is ITL Health Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from ITL Health Group dividends.
If you bought A$2,000 of ITL Health Group shares you are expected to receive A$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate ITL Health Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate ITL Health Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:ITD Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Oceania Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 1.7%
Australia Market Average Dividend Yield Market Cap Weighted Average of 420 Stocks 4.4%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.6%
Australia Bottom 25% Dividend Yield 25th Percentile 2.7%
Australia Top 25% Dividend Yield 75th Percentile 6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ASX:ITD Future Dividends Estimate Data
Date (Data in A$) Dividend per Share (annual) Avg. No. Analysts
ASX:ITD Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2017-02-16 0.000 0.000
2016-08-23 0.000 0.000
2016-02-16 0.000 0.000
2015-08-18 0.005 2.268
2015-02-18 0.010 4.308
2014-09-22 0.010 4.335
2014-08-19 0.010 4.461
2013-09-17 0.015 5.805
2013-08-15 0.015 4.589
2013-03-28 0.010 3.537
2010-03-03 0.000 0.000
2009-09-29 0.000 0.000
2009-08-31 0.000 0.000
2009-02-19 0.003 3.042

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as ITL Health Group has not reported any payouts.
  • Unable to verify if ITL Health Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of ITL Health Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as ITL Health Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess ITL Health Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can ITL Health Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. ITL Health Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

ITD Management

 What is the CEO of ITL Health Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Bill Mobbs
COMPENSATION A$585,820
AGE 59
TENURE AS CEO 8.5 years
CEO Bio

Mr. William Leonard Mobbs, also known as Bill, MBA, BSc., MAICD, is the Founder and Executive Chairman at MyHealthTest Pty Ltd. Mr. Mobbs is a Co-Founder of ITL Ltd. and has been its Interim Chief Executive Officer since August 18, 2010 and Executive Chairman since October 2010. He is the Founder and Executive Chairman of MyHealthTest Pty. Ltd. and Targeted Genomics Pty. Ltd. He served as the Chief Executive Officer of ITL Ltd. until October 2008. He served as Managing Director of ITL Ltd from October 2003 to October 2008 and served as its Joint Managing Director since October 24, 2004 and previously from 1999 to October 27, 2003. He has a strong track record for successfully turning product R&D into commercial outcome in the medical and healthcare markets and this is of particular relevance to Seeing Machines given the development of the glaucoma diagnostic device and other potential opportunities in these markets. He has 10 years of experience in developing, manufacturing, marketing and selling product into the global medical and healthcare industry. He has invented new concepts for a range of innovative medical products. He served as the Chairman of Admin Bandit Pty. Ltd. He served as the Non Executive Chairman of the Board at Seeing Machines Limited from November 2009 to December 31, 2011 and its Independent Non-Executive Director from October 18, 2006 to December 31, 2011. He also serves as a Director of not-for-profit organisations Hospital IP, ACT, NSW and QLD. He has been a Director of ITL Ltd. since August 18, 2010. He served as Executive Director of ITL Ltd. until October 2008. He served as a Director of Bilbo Holdings Pty Ltd., Hastcombe Pty Ltd., ITL Corporation Pty Ltd , ITL Design & Manufacturing Pty Ltd.,ITL Healthcare Pty Ltd , Noble House Group Pty Ltd., Surgicare Pty Ltd., GP Innovations Pty Ltd., Hygenia Corporation Pty Ltd and ITL Needle Guard Corporation Pty Ltd. He served as a Director of Connexxtion Pty. Ltd. and industry representative to the Therapeutics Goods Administration (TGA). His qualifications include a Bachelor of Science from the University of Queensland an MBA and he is also a Fellow of the Australian Institute of Company Directors.

CEO Compensation
  • Bill's compensation has been consistent with company performance over the past year.
  • Bill's remuneration is higher than average for companies of similar size in Australia.
Management Team Tenure

Average tenure of the ITL Health Group management team in years:

7.3
Average Tenure
  • The average tenure for the ITL Health Group management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Bill Mobbs

TITLE
Co-Founder
COMPENSATION
A$586K
AGE
59
TENURE
8.5 yrs

Trevor Doolan

TITLE
CFO, Company Secretary & Group Financial Controller
COMPENSATION
A$330K
TENURE
2.6 yrs

Craig Wilson

TITLE
Chief Operating Officer ITL BioMedical
COMPENSATION
A$317K

Stephanie Norrell

TITLE
Vice President of Sales & Marketing - North America
COMPENSATION
A$381K
TENURE
7.3 yrs

Narinder Kanda

TITLE
Vice President of Procurement & Strategic Relationships
COMPENSATION
A$366K
TENURE
7.6 yrs

Nick Cerneaz

TITLE
General Manager of MyHealthTest
COMPENSATION
A$266K
AGE
51
TENURE
3.2 yrs
Board of Directors Tenure

Average tenure of the ITL Health Group board of directors in years:

5.2
Average Tenure
  • The tenure for the ITL Health Group board of directors is about average.
Board of Directors

Bill Mobbs

TITLE
Co-Founder
COMPENSATION
A$586K
AGE
59
TENURE
8.3 yrs

Andrew Turnbull

TITLE
Non-Executive Director
COMPENSATION
A$108K
TENURE
5.2 yrs

Mark Peatey

TITLE
Non-Executive Director
COMPENSATION
A$108K
TENURE
4.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
X
Management checks
We assess ITL Health Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. ITL Health Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

ITD News

Simply Wall St News

Should You Worry About ITL Health Group Limited's (ASX:ITD) CEO Pay?

How Does Bill Mobbs's Compensation Compare With Similar Sized Companies. … At the time of writing our data says that ITL Health Group Limited has a market cap of AU$14m, and is paying total annual CEO compensation of AU$721k. … We looked at a group of companies with market capitalizations under AU$283m, and the median CEO compensation was AU$357k.

Simply Wall St -

Who Are The Top Investors In ITL Health Group (ASX:ITD)?

I am going to take a deep dive into ITL Health Group’s (ASX:ITD) most recent ownership structure, not a frequent subject of discussion among individual investors. … Ownership structure of a company has been found to affect share performance over time. … ASX:ITD Ownership Summary August 24th 18

Simply Wall St -

What Should You Know About ITL Health Group's (ASX:ITD) Return On Capital?

and looking to gauge the potential return on investment in ITL Health Group (ASX:ITD). … This share represents a portion of capital used by the company to operate the business, and it is important the company is able to use the capital base efficiently to create adequate cash flows for you as an investor. … Therefore, looking at how efficiently ITL Health Group is able to use capital to create earnings will help us understand your potential return.

Simply Wall St -

What does ITL Health Group's (ASX:ITD) Balance Sheet Tell Us About Its Future?

Investors are always looking for growth in small-cap stocks like ITL Health Group (ASX:ITD), with a market cap of AU$16.68m. … However, an important fact which most ignore is: how financially healthy is the business? … Evaluating financial health as part of your investment thesis is

Simply Wall St -

Should You Be Tempted To Buy ITL Health Group (ASX:ITD) At Its Current PE Ratio?

The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market. … and want to begin learning the link between ITL Health Group (ASX:ITD)’s fundamentals and stock market performance. … While this makes ITD appear like a great stock to buy, you might change your mind after I explain the assumptions behind the P/E ratio.

Simply Wall St -

Does ITL Health Group (ASX:ITD) Go Up With The Market?

If you are looking to invest in ITL Health Group’s (ASX:ITD), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your portfolio. … See our latest analysis for ITL Health Group An interpretation of ITD's beta ITL Health Group’s beta of 0.64 indicates that the company is less volatile relative to the diversified market portfolio. … This means that the change in ITD's value, whether it goes up or down, will be of a smaller degree than the change in value of the entire stock market index.

Simply Wall St -

Should You Be Tempted To Buy ITL Health Group (ASX:ITD) Because Of Its PE Ratio?

By comparing a stock’s price per share to its earnings per share, we are able to see how much investors are paying for each dollar of the company’s earnings. … Formula Price-Earnings Ratio = Price per share ÷ Earnings per share P/E Calculation for ITD Price per share = A$0.28 Earnings per share = A$0.012 ∴ Price-Earnings Ratio = A$0.28 ÷ A$0.012 = 23.9x The P/E ratio itself doesn’t tell you a lot; however, it becomes very insightful when you compare it with other similar companies. … At 23.9x, ITD’s P/E is lower than its industry peers (37.3x).

Simply Wall St -

What You Must Know About ITL Health Group's (ASX:ITD) Financial Strength

On top of this, ITD has produced cash from operations of AU$5.35M in the last twelve months, leading to an operating cash to total debt ratio of 101.25%, signalling that ITD’s debt is appropriately covered by operating cash. … In ITD’s case, it is able to generate 1.01x cash from its debt capital. … In ITD's, case, the ratio of 5.14x suggests that interest is appropriately covered, which means that debtors may be willing to loan the company more money, giving ITD ample headroom to grow its debt facilities.Next Steps: ITD’s debt level is appropriate for a company its size, and it is also able to generate sufficient cash flow coverage, meaning it has been able to put its debt in good use.

Simply Wall St -

Did ITL Health Group (ASX:ITD) Create Value For Investors Over The Past Year?

View our latest analysis for ITL Health Group Peeling the layers of ROE – trisecting a company’s profitability Return on Equity (ROE) is a measure of ITL Health Group’s profit relative to its shareholders’ equity. … Since ITL Health Group’s return does not cover its cost, with a difference of -3.09%, this means its current use of equity is not efficient and not sustainable. … This is called the Dupont Formula: Dupont Formula ROE = profit margin × asset turnover × financial leverage ROE = (annual net profit ÷ sales) × (sales ÷ assets) × (assets ÷ shareholders’ equity) ROE = annual net profit ÷ shareholders’ equity ASX:ITD Last Perf Mar 7th 18 Basically, profit margin measures how much of revenue trickles down into earnings which illustrates how efficient the business is with its cost management.

Simply Wall St -

Should You Be Concerned About ITL Health Group's (ASX:ITD) -21.10% Earnings Decline?

I use data from the most recent 12 months, which either annualizes the most recent 6-month earnings update, or in some cases, the most recent annual report is already the latest available financial data. … This suggests that whatever recent headwind the industry is experiencing, it’s hitting ITL Health Group harder than its peers.What does this mean? … Though if the entire industry is struggling to grow over time, it may be a signal of a structural change, which makes ITL Health Group and its peers a higher risk investment.

Simply Wall St -

ITD Company Info

Map
Description

ITL Health Group Limited develops, manufactures, distributes, and sells medical devices in Australia, the United States, the United Kingdom, Puerto Rico, France, and internationally. It operates through BioMed and MHT segments. The BioMed segment offers a range of tools for blood management and clinical procedures, as well as provides invasive blood monitoring and intravenous starter pack products to public and private hospitals. The MHT segment offers consumer pathology testing services, which include collecting blood sample from the convenience of home; processing the samples in a NATA accredited laboratory; and delivering test results to the individual through a secure Website. The company was formerly known as ITL Limited and changed its name to ITL Health Group Limited in February 2017. ITL Health Group Limited was founded in 1994 and is headquartered in Canberra, Australia.

Details
Name: ITL Health Group Limited
ITD
Exchange: ASX
Founded: 1994
A$10,293,451
70,989,319
Website: http://www.itlhealthgroup.com
Address: ITL Health Group Limited
10 Moore Street,
Level 3,
Canberra,
Australian Capital Territory, 2601,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX ITD Ordinary Shares Australian Securities Exchange AU AUD 29. Oct 2003
CHIA ITD Ordinary Shares Chi-X Australia AU AUD 29. Oct 2003
Number of employees
Current staff
Staff numbers
0
ITL Health Group employees.
Industry
Health Care Supplies
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/18 10:31
End of day share price update: 2019/02/08 00:00
Last estimates confirmation: 2017/08/21
Last earnings filing: 2018/08/31
Last earnings reported: 2018/06/30
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.